x
0
SCOTTRADE ACCOUNT IT'S TIME. It's time for an easier way to invest. Open a Scottrade Account
Apply Now

Mylan Inc (MYL)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Mylan's earnings

Delivery

Website notifications

Mobile App notifications

Add to/Remove from a Portfolio My Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
42.06 -0.24    -0.57%
19:44:51 GMT - Real-time CFD Data. Currency in USD ( Disclaimer )
Type: Equity
Market: United States
ISIN: NL0011031208 
CUSIP: 001103120

  • Volume: 3,061,164
  • Bid/Ask: 42.05 / 42.06
  • Day's Range: 41.86 - 42.30
START TRADING NOW
Mylan 42.06 -0.24 -0.57%

MYL Overview

 
Information about the Mylan Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close42.3
Day's Range41.86 - 42.3
Revenue10.3B
Open42.21
52 wk Range33.6 - 50.4
EPS0.51
Volume3,061,164
Market Cap22.63B
Dividend (Yield)0 (N/A)
Average Vol. (3m)7,612,729
P/E Ratio82.87
Beta1.12
1-Year Change - 9.63%
Shares Outstanding535,105,253
Next Earnings DateMar 01, 2017

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Sell Sell Neutral Strong Buy Buy
Technical Indicators BUY Sell Strong Sell Strong Buy Strong Sell
Summary Neutral Sell Sell Strong Buy Neutral

Candlestick Patterns

Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Doji Star Bearish 1W Current
Completed Patterns
Three Inside Up 1M 2 Dec 16
Doji Star Bearish 1W 2 Feb 05, 2017
Bullish Engulfing 1W 3 Jan 29, 2017

Mylan Inc News & Analysis

Mylan Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 42.06 42.05 42.06 3,061,164 -0.57% USD 19:44:51  
  Switzerland 43.730 0.000 0.000 0 0.00% CHF 21/02  
  Munich 40.460 0.000 0.000 500 +2.47% EUR 13:20:00  
  Stuttgart 39.700 39.720 39.880 200 -0.87% EUR 17:05:00  
  Tel Aviv 15,610 15,610 15,630 243,465 -0.32% ILS 15:24:00  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery

Website notifications

Mobile App notifications

  Name Last High Low Chg. Chg. % Vol. Time
  Tesla 274.06 283.40 272.60 -3.33 -1.20% 5.90M 19:44:50  
  Apple 136.80 137.12 136.11 +0.10 +0.07% 13.64M 19:44:48  
  AMD 14.248 14.500 14.040 +0.248 +1.77% 60.10M 19:44:43  
  DryShips 2.75 3.33 2.62 -0.53 -16.16% 24.61M 19:44:30  
  Amazon.com 856.17 858.42 852.18 -0.27 -0.03% 1.97M 19:44:51  
  Facebook 136.46 136.79 133.47 +2.73 +2.05% 22.84M 19:44:45  
  Intel 35.80 36.40 35.79 -0.72 -1.97% 19.96M 19:44:47  
  Bank of America 24.79 24.95 24.54 +0.01 +0.04% 65.50M 19:44:50  
  JPMorgan 90.95 91.30 90.42 -0.06 -0.07% 7.08M 19:44:48  
  Goldman Sachs 251.39 252.35 250.00 -0.37 -0.15% 1.70M 19:43:44  

Mylan Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

35000

Equity Type

ORD

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty. Its Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, cream or ointment form, as well as API. Its Specialty segment is focused on respiratory and allergy therapies. The EpiPen Auto-Injector, which is used in the treatment of severe allergic reactions, is an epinephrine auto-injector. Its Perforomist Inhalation Solution is a long-acting beta2-adrenergic agonist indicated for the maintenance treatment of bronchoconstriction in chronic obstructive pulmonary disorder (COPD) patients. The Company also markets ULTIVA, which is an analgesic agent.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
National Futures Association (United States), U.S. Commodity Futures Trading Commission (United States), The Financial Conduct Authority (United Kingdom), Australian Securities and Investments Commission (Australia), Financial Industry Regulatory Authority (United States), Investment Industry Regulatory Organization of Canada (Canada), Securities and Exchange Commission (United States), The Securities and Futures Commission (Hong Kong) $250 Start Trading
National Futures Association (United States), National Securities Depository (India), U.S. Commodity Futures Trading Commission (United States), The Financial Conduct Authority (United Kingdom), Financial Industry Regulatory Authority (United States), Investment Industry Regulatory Organization of Canada (Canada), Securities and Exchange Board of India (India), Securities and Exchange Commission (United States), The Securities and Futures Commission (Hong Kong), Securities Investor Protection Corporation (United States) $2000 Start Trading
Securities and Exchange Commission (United States) $2500 Start Trading

My Sentiments

Add your sentiment:
or
 
Members' Sentiments:
Bullish
100%
Bearish
0%

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
 
 
 
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Add Chart to Comment
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.